Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
Cancer vaccines often fail to generate clinically relevant effects. Here, the authors generate a nanosized cytomembrane vaccine based on fusion between dendritic cells and cancer cells, and show them to activate anti-tumor immune responses via their antigen presenting and T-cell activating functions...
Saved in:
Main Authors: | Wen-Long Liu, Mei-Zhen Zou, Tao Liu, Jin-Yue Zeng, Xue Li, Wu-Yang Yu, Chu-Xin Li, Jing-Jie Ye, Wen Song, Jun Feng, Xian-Zheng Zhang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/67ae9c77ce0a4c3384f5b7c2f11709b8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy
by: Dong Y, et al.
Published: (2020) -
Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine
by: Li B, et al.
Published: (2016) -
Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells
by: Huang F, et al.
Published: (2020) -
Prodigiosin found in Serratia marcescens y2 initiates phototoxicity in the cytomembrane
by: Wang,Fei, et al.
Published: (2013) -
CpG-Based Nanovaccines for Cancer Immunotherapy
by: Chen W, et al.
Published: (2021)